I agree that this site is using cookies. You can find further informations here.
X
Messersmith, W. A.
133  results:
Search for persons X
?
1

A multicenter, randomized phase 2 study to establish combin..:

Enzler, T. ; Nguyen, A. ; Misleh, J....
European Journal of Cancer.  201 (2024)  - p. 113950 , 2024
Link: https://doi.org/10.1016/..
 
?
2

128P A phase I dose escalation and expansion trial of LYT-2..:

Falchook, G. ; Rasco, D. ; Papadopoulos, K....
Immuno-Oncology and Technology.  20 (2023)  - p. 100600 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Avelumab or talazoparib in combination with binimetinib in ..:

Rodon Ahnert, J. ; Tan, D.S.-W. ; Garrido-Laguna, I....
ESMO Open.  8 (2023)  4 - p. 101584 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Outcome of neoadjuvant treatment for pancreatic cancer in e..:

Oba, A ; Wu, Y H A ; Lieu, C H...
British Journal of Surgery.  108 (2021)  8 - p. 976-982 , 2021
Link: https://doi.org/10.1093/..
 
?
5

Sacituzumab govitecan, a Trop-2-directed antibody-drug conj..:

Bardia, A. ; Messersmith, W.A. ; Kio, E.A....
Annals of Oncology.  32 (2021)  6 - p. 746-756 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Induction of ADAM10 Drives Fibrosis and Therapeutic Resista..:

Mueller, A. ; Oweida, A. ; Bhatia, S....
International Journal of Radiation Oncology*Biology*Physics.  105 (2019)  1 - p. S208 , 2019
Link: https://doi.org/10.1016/..
 
?
7

Topoisomerase IIα mediates TCF-dependent epithelial–mesench..:

Zhou, Q ; Abraham, A D ; Li, L...
Oncogene.  35 (2016)  38 - p. 4990-4999 , 2016
Link: https://doi.org/10.1038/..
 
?
8

Erratum to: Phase II study of selumetinib (AZD6244, ARRY-14..:

Hochster, H. S. ; Uboha, N. ; Messersmith, W....
Cancer Chemotherapy and Pharmacology.  75 (2014)  1 - p. 25-25 , 2014
Link: https://doi.org/10.1007/..
 
?
9

Phase II study of selumetinib (AZD6244, ARRY-142886) plus i..:

Hochster, H. S. ; Uboha, N. ; Messersmith, W....
Cancer Chemotherapy and Pharmacology.  75 (2014)  1 - p. 17-23 , 2014
Link: https://doi.org/10.1007/..
 
?
10

587 Phase 1 Dose-escalation Study of PF-04449913, an Oral H..:

Wagner, A. ; Messersmith, W. ; Shaik, N....
European Journal of Cancer.  48 (2012)  - p. 180 , 2012
Link: https://doi.org/10.1016/..
 
?
11

584 Preclinical and Clinical Evaluation of the Combination ..:

Ma, W. ; Weekes, C. ; Pawaskar, D.K....
European Journal of Cancer.  48 (2012)  - p. 179 , 2012
Link: https://doi.org/10.1016/..
 
?
12

A phase I study of sorafenib and vorinostat in patients wit..:

Dasari, A. ; Gore, L. ; Messersmith, W. A....
Investigational New Drugs.  31 (2012)  1 - p. 115-125 , 2012
Link: https://doi.org/10.1007/..
 
?
13

A phase I study of sunitinib combined with modified FOLFOX6..:

Leong, S. ; Eckhardt, S. G. ; Chan, E....
Cancer Chemotherapy and Pharmacology.  70 (2012)  1 - p. 65-74 , 2012
Link: https://doi.org/10.1007/..
 
?
14

588 A First-in-patient Phase I Study of the Novel Gamma Sec..:

Messersmith, W.A. ; LoRusso, P.M. ; Cleary, J.M....
European Journal of Cancer.  48 (2012)  - p. 180 , 2012
Link: https://doi.org/10.1016/..
 
?
15

263 Validation of Preclinical Colorectal Cancer Models Agai..:

Tan, A. ; Britt, B. ; Astling, D....
European Journal of Cancer.  48 (2012)  - p. 81 , 2012
Link: https://doi.org/10.1016/..
 
1-15